Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2013, Article ID 358562, 8 pages
http://dx.doi.org/10.1155/2013/358562
Research Article

Effects of Emotional Response on Adherence to Antihypertensive Medication and Blood Pressure Improvement

1Denver Health Medical Center, Denver, CO, USA
2Department of Family Medicine, University of Colorado and Level One Physicians, Denver Health, MC 1914, 301 West 6th Avenue, Denver, CO 80204, USA
3Driscoll Consulting, Boulder, CO 80303, USA

Received 17 September 2012; Revised 27 November 2012; Accepted 11 December 2012

Academic Editor: Claudio Borghi

Copyright © 2013 Robert D. Keeley and Margaret Driscoll. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Adherence to Long-Term Therapies: Evidence for Action, World Health Organization, Geneva, Switzerland, 2003.
  2. D. G. Pittman, Z. Tao, W. Chen, and G. D. Stettin, “Antihypertensive medication adherence and subsequent healthcare utilization and costs,” American Journal of Managed Care, vol. 16, no. 8, pp. 568–576, 2010. View at Google Scholar · View at Scopus
  3. M. R. Dimatteo, P. J. Giordani, H. S. Lepper, and T. W. Croghan, “Patient adherence and medical treatment outcomes: a meta-analysis,” Medical Care, vol. 40, no. 9, pp. 794–811, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. L. D. Esposti, S. Saragoni, S. Benemei et al., “Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients,” ClinicoEconomics and Outcomes Research, vol. 3, no. 1, pp. 47–54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. W. B. Kannel, T. R. Dawber, and D. L. McGee, “Perspectives on systolic hypertension. The Framingham Study,” Circulation, vol. 61, no. 6, pp. 1179–1182, 1980. View at Google Scholar · View at Scopus
  6. P. M. Ho, J. S. Rumsfeld, F. A. Masoudi et al., “Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus,” Archives of Internal Medicine, vol. 166, no. 17, pp. 1836–1841, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. P. A. Heidenreich, “Patient adherence: the next frontier in quality improvement,” American Journal of Medicine, vol. 117, no. 2, pp. 130–132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. D, “Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research,” Medical Care, vol. 42, no. 3, pp. 200–209, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Osterberg and T. Blaschke, “Adherence to medication,” The New England Journal of Medicine, vol. 353, no. 5, pp. 487–497, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. R. B. Haynes, E. Ackloo, N. Sahota, H. P. McDonald, and X. Yao, “Interventions for enhancing medication adherence,” Cochrane Database of Systematic Reviews, no. 2, p. CD000011, 2008. View at Google Scholar · View at Scopus
  11. J. F. Steiner, P. M. Ho, B. L. Beaty et al., “Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension,” Circulation, vol. 2, no. 5, pp. 451–457, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. F. Steiner, “Can we identify clinical predictors of medication adherence and should we?” Medical Care, vol. 48, no. 3, pp. 193–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. D. Keeley, A. J. Davidson, L. A. Crane, B. Matthews, and W. Pace, “An association between negatively biased response to neutral stimuli and antidepressant nonadherence,” Journal of Psychosomatic Research, vol. 62, no. 5, pp. 535–544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. P. Nau, J. E. Aikens, and A. M. Pacholski, “Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus,” Gender Medicine, vol. 4, no. 3, pp. 205–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. H. C. Kraemer, E. Frank, and D. J. Kupfer, “Moderators of treatment outcomes: clinical, research, and policy importance,” Journal of the American Medical Association, vol. 296, no. 10, pp. 1286–1289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. H. C. Kraemer, E. Stice, A. Kazdin, D. Offord, and D. Kupfer, “How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors,” American Journal of Psychiatry, vol. 158, no. 6, pp. 848–856, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. R. D. Keeley and M. Driscoll, “A moderator-mediator analysis of coronary heart disease mortality,” Journal of Psychosomatic Research, vol. 69, no. 6, pp. 549–554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. F. Steiner and A. V. Prochazka, “The assessment of refill compliance using pharmacy records: methods, validity, and applications,” Journal of Clinical Epidemiology, vol. 50, no. 1, pp. 105–116, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. S. B. Calvert, J. M. Kramer, K. J. Anstrom, L. A. Kaltenbach, J. A. Stafford, and N. M. Allen Lapointe, “Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial,” American Heart Journal, vol. 163, no. 4, pp. 657–665, 2012. View at Google Scholar
  20. R. M. Nesse and P. C. Ellsworth, “Evolution, emotions, and emotional disorders,” American Psychologist, vol. 64, no. 2, pp. 129–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Ekman and W. V. Friesen, Emotion in the Human Face, Pergamon Publishing, Elmsford, NY, USA, 1972.
  22. M. Reker, P. Ohrmann, A. V. Rauch et al., “Individual differences in alexithymia and brain response to masked emotion faces,” Cortex, vol. 46, no. 5, pp. 658–667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Y. Seiferth, K. Pauly, U. Habel et al., “Increased neural response related to neutral faces in individuals at risk for psychosis,” NeuroImage, vol. 40, no. 1, pp. 289–297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. G. Jung, Analytical Psychology: Its Theory and Practice, Random House, New York, NY, USA, 1968.
  25. P. Ekman, “An argument for basic emotions,” Cognition Emotion, vol. 6, pp. 169–200, 1992. View at Google Scholar
  26. R. Horne, J. Weinman, and M. Hankins, “The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication,” Psychology and Health, vol. 14, no. 1, pp. 1–24, 1999. View at Google Scholar · View at Scopus
  27. C. Brown, D. R. Battista, R. Bruehlman, S. S. Sereika, M. E. Thase, and J. Dunbar-Jacob, “Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence,” Medical Care, vol. 43, no. 12, pp. 1203–1207, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. U. Khanderia, K. A. Townsend, S. R. Erickson, J. Vlasnik, R. L. Prager, and K. A. Eagle, “Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes,” Annals of Pharmacotherapy, vol. 42, no. 2, pp. 192–199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. H. De Weert-Van Oene, C. A. J. De Jong, F. Jörg, and G. J. P. Schrijvers, “The helping alliance questionnaire: psychometric properties in patients with substance dependence,” Substance Use and Misuse, vol. 34, no. 11, pp. 1549–1569, 1999. View at Google Scholar · View at Scopus
  30. E. L. O'Hea, S. Moon, K. B. Grothe et al., “The interaction of locus of control, self-efficacy, and outcome expectancy in relation to HbA1c in medically underserved individuals with type 2 diabetes,” Journal of Behavioral Medicine, vol. 32, no. 1, pp. 106–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Bush, J. Russo, E. Ludman et al., “Perceived self-efficacy for depression self-management. A reliable and valid self-report measure with predictive validity,” in Proceedings of the American Psychological Society Meeting, Toronto, Canada, 2001.
  32. A. Luszczynska, U. Scholz, and R. Schwarzer, “The general self-efficacy scale: multicultural validation studies,” Journal of Psychology, vol. 139, no. 5, pp. 439–457, 2005. View at Google Scholar · View at Scopus
  33. M. Jerusalem and R. Schwarzer, “Self-efficacy as a resource factor in stress appraisal processes,” in Self-Efficacy: Thought Control of Action, R. Schwarzer, Ed., pp. 195–213, Hemisphere, Washington, DC, USA, 1992. View at Google Scholar
  34. J. E. Ware and C. D. Sherbourne, “The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection,” Medical Care, vol. 30, no. 6, pp. 473–483, 1992. View at Google Scholar · View at Scopus
  35. M. R. D, “Social support and patient adherence to medical treatment: a meta-analysis,” Health Psychology, vol. 23, no. 2, pp. 207–218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Fang, J. Wylie-Rosett, H. W. Cohen, R. C. Kaplan, and M. H. Alderman, “Exercise, body mass index, caloric intake, and cardiovascular mortality,” American Journal of Preventive Medicine, vol. 25, no. 4, pp. 283–289, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Löwe, K. Kroenke, and K. Gräfe, “Detecting and monitoring depression with a two-item questionnaire (PHQ-2),” Journal of Psychosomatic Research, vol. 58, no. 2, pp. 163–171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. R. B. D'Agostino Sr., S. Grundy, L. M. Sullivan, and P. Wilson, “Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation,” Journal of the American Medical Association, vol. 286, no. 2, pp. 180–187, 2001. View at Google Scholar · View at Scopus
  39. R. N. Guzder, W. Gatling, M. A. Mullee, R. L. Mehta, and C. D. Byrne, “Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study,” Diabetic Medicine, vol. 22, no. 5, pp. 554–562, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. H. C. Kraemer, G. T. Wilson, C. G. Fairburn, and W. S. Agras, “Mediators and moderators of treatment effects in randomized clinical trials,” Archives of General Psychiatry, vol. 59, no. 10, pp. 877–883, 2002. View at Google Scholar · View at Scopus
  41. H. C. Kraemer, K. K. Lowe, and D. J. Kupfer, To Your Health: How to Understand What Research Tells Us About Risk, vol. 1, Oxford University Press, Oxford, UK, 2005.
  42. H. C. Kraemer and C. M. Blasey, “Centring in regression analyses: a strategy to prevent errors in statistical inference,” International Journal of Methods in Psychiatric Research, vol. 13, no. 3, pp. 141–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. W. J. Katon, M. Von Korff, E. H. B. Lin et al., “The pathways study: a randomized trial of collaborative care in patients with diabetes and depression,” Archives of General Psychiatry, vol. 61, no. 10, pp. 1042–1049, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S. J. Pocock, S. E. Assmann, L. E. Enos, and L. E. Kasten, “Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems,” Statistics in Medicine, vol. 21, no. 19, pp. 2917–2930, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Kroenke, R. L. Spitzer, and J. B. W. Williams, “The patient health questionnaire-2: validity of a two-item depression screener,” Medical Care, vol. 41, no. 11, pp. 1284–1292, 2003. View at Publisher · View at Google Scholar · View at Scopus